The North America Electric Vehicle (EV) Battery Components Market, valued at USD 15.40 billion in 2025, is anticipated to surge to USD 59.85 billion by 2035, with a CAGR of 14.54%. Dominated by technological advances and stringent localization policies under the Inflation Reduction Act (IRA), this growth is driven by increasing EV adoption across diverse platforms, including passenger and commerci...
The North America Electric Vehicle (EV) Battery Components Market, valued at USD 15.40 billion in 2025, is anticipated to surge to USD 59.85 billion by 2035, with a CAGR of 14.54%. Dominated by technological advances and stringent localization policies under the Inflation Reduction Act (IRA), this growth is driven by increasing EV adoption across diverse platforms, including passenger and commercial vehicles. Emphasizing lithium-ion battery dominance, the market sees significant investments in m
Micron Technology Inc (NASDAQ:MU) shares rose 7% on Thursday after the company announced plans to invest up to $3 billion to strengthen the U.S. semiconductor supply chain and support future manufacturing capacity. The investment includes $500 million in strategic financing support for...
Micron Technology Inc (NASDAQ:MU) shares rose 7% on Thursday after the company announced plans to invest up to $3 billion to strengthen the U.S. semiconductor supply chain and support future manufacturing capacity. The investment includes $500 million in strategic financing support for...
Silicon Motion Technology is expanding in enterprise SSDs with its MonTitan controller platform, targeting AI, cloud and hyperscale demand with advanced storage solutions.
Silicon Motion Technology is expanding in enterprise SSDs with its MonTitan controller platform, targeting AI, cloud and hyperscale demand with advanced storage solutions.
Get a sneak peak into the whirlwind hours that followed for British wildcard Arthur Fery, after his historic victory over Flavio Cobolli to reach the Wimbledon semi-finals.
Get a sneak peak into the whirlwind hours that followed for British wildcard Arthur Fery, after his historic victory over Flavio Cobolli to reach the Wimbledon semi-finals.
Solskin/DigitalVision via Getty Images This is my first coverage on Sellas Life Sciences ( SLS ). The company has recently experienced a price surge, potentially driven by heightened expectations surrounding the upcoming data results from its Phase 3 REGAL Trial, which is evaluating galinpepimut-S as a maintenance therapy for acute myeloid leukemia (AML). In this article, I will discuss the study ...
Solskin/DigitalVision via Getty Images This is my first coverage on Sellas Life Sciences ( SLS ). The company has recently experienced a price surge, potentially driven by heightened expectations surrounding the upcoming data results from its Phase 3 REGAL Trial, which is evaluating galinpepimut-S as a maintenance therapy for acute myeloid leukemia (AML). In this article, I will discuss the study design, the history of cancer vaccines—specifically NeuVax—and offer my opinion on the Phase 3 trial. Due to the high expectations and the relatively low chance the trial will be successful, I am issuing a "Sell" rating. Introduction And The Phase 3 REGAL Trial The primary catalyst for the current bullish momentum is imminent data from the Phase 3 trial. It was recently reported that 78 events were accumulated out of the 80 events needed to trigger unblinding. This triggered excitement around positive topline analysis due to slow event accumulation, but in my opinion, this is due to healthier patients being in the trial as a direct result of the exclusion criteria. The second reason I am skeptical stems from the past failures of high-affinity peptides. The Failure Of High-Affinity Vaccines To understand why Sellas’ peptide vaccine is similar to NeuVax, we must examine the mechanisms of T cell exhaustion and peptide-to-MHC Class I binding affinities. Active immunotherapy relies on training the host immune system to recognize and eliminate tumor-associated antigens. Sellas targets the Wilms Tumor 1 protein. Like its failed predecessor, nelipepimut-S (NeuVax), galinpepimut is an immunodominant epitope with high binding affinity to MHC Class I molecules. The idea behind high-affinity peptides assumes that stronger binding equals a more robust immune response. This is correct at first, but such cells are prone to immune exhaustion. Second, due to thymic deletion, naïve T cells that bind strongly with self-peptides, like Wilms tumor, are deleted, meaning only naïve T cells with l...
Flexport CEO Ryan Petersen joins Bloomberg Open Interest to explain why the biggest threat to global shipping isn't the Strait of Hormuz—it's still the Red Sea. He breaks down the surge in imports driven by tariff uncertainty, why companies are stockpiling inventory after the COVID supply chain crisis, and how Panama Canal drought risks could create the next bottleneck. (Source: Bloomberg)
Flexport CEO Ryan Petersen joins Bloomberg Open Interest to explain why the biggest threat to global shipping isn't the Strait of Hormuz—it's still the Red Sea. He breaks down the surge in imports driven by tariff uncertainty, why companies are stockpiling inventory after the COVID supply chain crisis, and how Panama Canal drought risks could create the next bottleneck. (Source: Bloomberg)
boonstudio/iStock via Getty Images Recent MSOS Volatility and Uncertainty AdvisorShares Pure US Cannabis ETF ( MSOS ) is the largest cannabis ETF and is based on the US cannabis market. Recently, there has been more volatility due to bullish sentiment since President Trump’s executive order in December 2025 called for the expedited process of moving marijuana from Schedule 1 to Schedule 3. Additio...
boonstudio/iStock via Getty Images Recent MSOS Volatility and Uncertainty AdvisorShares Pure US Cannabis ETF ( MSOS ) is the largest cannabis ETF and is based on the US cannabis market. Recently, there has been more volatility due to bullish sentiment since President Trump’s executive order in December 2025 called for the expedited process of moving marijuana from Schedule 1 to Schedule 3. Additionally, in compliance with the executive order, the Department of Justice (DOJ) and Drug Enforcement Administration (DEA) announced that medical cannabis products and FDA-approved products containing marijuana are now in Schedule 3 and a separate hearing on whether to reschedule cannabis as a whole including for recreational use began June 29, 2026, and runs through July 15. Overall, extremely long-awaited news for cannabis investors. That was until this past week when the DEA released the list of interested persons allowed to participate in the ongoing hearing. The participant list appears heavily weighted toward opponents of broader rescheduling, which has raised investor concern about the path forward. The DEA also stated that the government has a responsibility to provide evidence to support the rescheduling of marijuana. These regulations on the hearing were a bucket of cold water on many cannabis investors as it seems like the odds are stacked against the cannabis industry. There are a couple of points of view to consider though. The first, as discussed, is that the DEA has completely stacked the prohibition side and it’s a dead end for cannabis for the near future. The second, by allowing only prohibition groups to speak, if cannabis is rescheduled, provides fewer avenues of legally stalling or potentially blocking the rescheduling from prohibition groups. Regardless, it’s fair to say most investors do not know what exactly is going on, but the uncertainty from investors is prevalent in the recent price movements in MSOS ranging from $5.50 to $4.40. MSOS Value Analysi...
Meta’s decision to make its in-house chip could be a boon for Applied Materials, Lam Research, and KLA, which all make equipment that turns raw silicon wafers into microchips.
Meta’s decision to make its in-house chip could be a boon for Applied Materials, Lam Research, and KLA, which all make equipment that turns raw silicon wafers into microchips.
GlobalWafers deepens long-term strategic collaboration with Micron to strengthen U.S. semiconductor supply chain and critical materials supply resilience North Texas e-News
GlobalWafers deepens long-term strategic collaboration with Micron to strengthen U.S. semiconductor supply chain and critical materials supply resilience North Texas e-News
Germany is buying US Tomahawk missiles even as Europe races to build its own defense industry. Bloomberg Economics' Becca Wasser joins Open Interest to explain why America is prioritizing its own missile stockpiles, why Europe still depends on U.S. weapons, and how China's industrial strength is reshaping the global military balance. (Source: Bloomberg)
Germany is buying US Tomahawk missiles even as Europe races to build its own defense industry. Bloomberg Economics' Becca Wasser joins Open Interest to explain why America is prioritizing its own missile stockpiles, why Europe still depends on U.S. weapons, and how China's industrial strength is reshaping the global military balance. (Source: Bloomberg)
primeimages/iStock via Getty Images By JJ Kinahan It looks like it could be another day of intraday volatility in trading. The three major indices are trying to stay on an upward climb in the early going as investors try to wrap their heads around the rocky geopolitical tensions in the Middle East while largely discounting the action there. The U.S. and Iran continued to trade overnight strikes fo...
primeimages/iStock via Getty Images By JJ Kinahan It looks like it could be another day of intraday volatility in trading. The three major indices are trying to stay on an upward climb in the early going as investors try to wrap their heads around the rocky geopolitical tensions in the Middle East while largely discounting the action there. The U.S. and Iran continued to trade overnight strikes for the second time in a row, with what looks like little effort to end the escalation. After yesterday’s rickety day, today looks a little calmer to start, but remember so much can happen throughout a session. Crude oil prices are jumping around again amid reports of limited traffic going through the Strait of Hormuz. WTI crude was up nearly 1% and approaching $74 a barrel early on before reversing course, falling 0.69% to just above $73 a barrel, flirting with the $72 range. To start the day, the Dow Jones Industrial Average is hugging the flat line, dipping slightly above and under it, while the S&P 500 Index is edging higher by 0.31%. The Nasdaq Composite —which saw deep dives yesterday before inching into positive territory at the close — is strengthening again, up 0.51%. We typically see this kind of summer trading in July, with lower volumes as folks take vacations and the like. What is surprising is that investors appear to be overlooking much of the friction in the Middle East. Tech stocks were on an upward climb, with Micron ( MU ) shares trading higher by 6.5%, Marvell Technology ( MRVL ) gaining 6%, Broadcom ( AVGO ) up 3.7%, and Advanced Micro Devices ( AMD ) tracking up by 3.9%. Software stocks aren’t trading as well. Microsoft ( MSFT ) and IBM ( IBM ) shares were in a freefall early on after Bloomberg reported that Starbucks ( SBUX ) was developing in-house tools — aided unsurprisingly by artificial intelligence — that would replace the Microsoft and IBM inventory and management tools the company currently uses. Some of those Starbucks systems could roll out be...
Looking at the universe of stocks we cover at Dividend Channel, on 7/13/26, CF Bankshares Inc (Symbol: CFBK) will trade ex-dividend, for its quarterly dividend of $0.09, payable on 7/21/26. As a percentage of CFBK's recent stock price of $31.15, this dividend works out to appro
Looking at the universe of stocks we cover at Dividend Channel, on 7/13/26, CF Bankshares Inc (Symbol: CFBK) will trade ex-dividend, for its quarterly dividend of $0.09, payable on 7/21/26. As a percentage of CFBK's recent stock price of $31.15, this dividend works out to appro
Looking at the universe of stocks we cover at Dividend Channel, on 7/10/26, Morningstar Inc (Symbol: MORN) will trade ex-dividend, for its quarterly dividend of $0.50, payable on 7/31/26. As a percentage of MORN's recent stock price of $162.31, this dividend works out to approx
Looking at the universe of stocks we cover at Dividend Channel, on 7/10/26, Morningstar Inc (Symbol: MORN) will trade ex-dividend, for its quarterly dividend of $0.50, payable on 7/31/26. As a percentage of MORN's recent stock price of $162.31, this dividend works out to approx
In early trading on Thursday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7.5%. Year to date, Honeywell International registers a 42.2% gain. And the worst performing Dow component thus far
In early trading on Thursday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7.5%. Year to date, Honeywell International registers a 42.2% gain. And the worst performing Dow component thus far